Fig. 2. EV-MIAT enhances osteosarcoma cell proliferation and angiogenesis.
A A volcano plot of differentially expressed mRNAs in osteosarcoma samples from the GSE41445 dataset. The abscissa represents −log10 (p value), the ordinate represents logFC, the red dots indicate significantly upregulated genes and the green dots indicate significantly downregulated genes in osteosarcoma samples. B A heat map of differentially expressed lncRNAs in osteosarcoma samples from the GSE41445 dataset. The abscissa represents the sample number and the ordinate represents the lncRNA; the left dendrogram refers to the lncRNA expression cluster and the histogram at the upper right refers to a color gradation; each small square in the figure represents the expression of a lncRNA in a sample. C Morphological characterization of the serum-EVs observed using a TEM. Scale bar = 100 nm. D The size distribution of EVs analyzed by NTA. E Western blot analysis of CD9, CD81, Alix, and Calnexin proteins in osteosarcoma cells and the isolated EVs. F MIAT expression was determined by RT-qPCR in the serum-EVs from healthy individuals and osteosarcoma patients (n = 68). G Internalization of EVs by MG63 cells observed under a fluorescence microscope (PKH67-labeled EVs show green fluorescence and DAPI-labeled nucleus show blue fluorescence) (scale bar: 25 μm). H Immunofluorescence analysis of Flag-labeled MIAT in MG63 cells following incubation with EVs (Flag-labeled MIAT shows red fluorescence and DAPI-labeled nucleus shows blue fluorescence) (scale bar: 25 μm). I MIAT expression was determined by RT-qPCR in U2OS and MG63 cells incubated with EV-MIAT. J Proliferation of EV-treated U2OS and MG63 cells measured by CCK-8 assay. K Angiogenesis of EV-treated U2OS and MG63 cells measured by microtubule formation in vitro. *p < 0.05, **p < 0.01. All experiments were conducted three times independently.
